NCT01380054View on ClinicalTrials.gov

Pulmonary Hypertension, Quality of Life and Psychosocial Factors

CompletedOBSERVATIONAL

Enrollment

55

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

May 20, 2016

Study Completion Date

May 20, 2016

Conditions

Pulmonary Hypertension

Interventions

BEHAVIORAL

Evaluation of quality of life

-Psychological interviews-Questionaires : HAD, STAI, CHIP, MHLC, WCC, SSQ scales-Quality of life : SF-36

Trial Locations (1)

34295

CHU, Montpellier

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University Hospital, Montpellier

OTHER

NCT01380054 - Pulmonary Hypertension, Quality of Life and Psychosocial Factors | Biotech Hunter | Biotech Hunter